raltegravir-potassium and Dermatitis--Atopic

raltegravir-potassium has been researched along with Dermatitis--Atopic* in 1 studies

Other Studies

1 other study(ies) available for raltegravir-potassium and Dermatitis--Atopic

ArticleYear
Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection.
    BMJ case reports, 2015, Nov-24, Volume: 2015

    We report a case of a new diagnosis of HIV with an extremely high viral load presenting with HIV encephalopathy, in a 54-year-old woman who had been treated with 2 years of extended high-dose immunosuppressant therapy for a recalcitrant pruritic rash before diagnosis.

    Topics: AIDS Dementia Complex; Anti-HIV Agents; Black People; CD4 Lymphocyte Count; Darunavir; Delayed Diagnosis; Dermatitis, Atopic; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV-1; Humans; Immunosuppressive Agents; Middle Aged; Predictive Value of Tests; Prednisolone; Raltegravir Potassium; Ritonavir; Treatment Outcome; Viral Load

2015